Blood Transfusion Devices Market, By Product Type (Pathogen Reduction System, Apheresis Devices, Blood Component Separator, Blood Bag & Accessory, Venous Access Devices, Others (Filters, Blood Mixer, Fridge & Freezer)), By End User (Hospital, Ambulatory Surgical Centers, Blood Bank, Others (Research & Academic Institutes, etc.)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Oct 2023

Code : CMI4156

Pages :180

Formats :

Excel and PDF

Industry : Medical Devices

Market Challenges And Opportunities

Global Blood Transfusion Devices Market - Drivers

Rising number of surgeries: Cardiovascular procedures, Cesarean section procedures, and trauma and accident injuries are the most common surgeries that require blood transfusion. According to report published by World Health Organization (WHO), in 2021, worldwide cesarean section rates have increased from around 7% in 1990 to 21% in 2021, and are expected to continue increasing over the next decade. If current trends continue, Eastern Asia (63%), Latin America and the Caribbean (54%), Western Asia (50%), Northern Africa (48%) Southern Europe (47%), and Australia and New Zealand (45%) will have the highest rates by 2030. As a result, increasing number of surgical procedures is expected to drive growth of the global blood transfusion devices market.
Organic growth strategies such as product launch: Increasing number of organic growth strategies such as product launch by key market players is expected to drive the market growth over the forecast period. For instance, in May 2022, Vitestro, a medical robotics company, launched world's most advanced autonomous blood drawing device at the annual meeting of the Netherlands Society for Clinical Chemistry and Laboratory Medicine (NVKC) held in Rotterdam. Vitestro's device combines AI-based, ultrasound-guided 3D reconstruction with robotic needle insertion to ensure accurate and secure blood collection.

Global Blood Transfusion Devices Market: Restraint

Shortage of blood bags and other accessories required for blood collection: One of the key factor hindering the market growth is shortage of blood bags required for blood collection. For instance, in March 2022, America's Blood Centers (ABC) and Blood Centers of America, Inc. (BCA) publihsed a joint letter outlining the issues faced by the blood centers due to shortage of Fresenius Kabi manufactured "BioFlex" blood bags. Members of the ABC and the BCA stated that 10-15% of all whole blood collections are impacted by this shortage. If this shortage continues, the blood transfusion devices market in the North America region will be heavily impacted.
Counterbalance: To control the shortage of blood bags, the key players should take proper preventive measures to control the shortage and discuss with the regulatory authorities to properly preserve the blood bags.